4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-058334
Director sold 30,000 shares at $70.05 ($2,101,590)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Director | 2020-11-12 | Sale | −30,000 | $70.05 | $2,101,590 | 25,000 | D |
| Open-market sales · 30,000 sh · avg $70.05 · $2,101,590 | |||||||
Loading xslF345X03/doc4.xml…